Targeted fat metabolism
Stimulates fat breakdown and inhibits fat storage without systemic growth hormone effects.
AOD-9604 is administered as a subcutaneous injection, typically once daily in the morning on an empty stomach. Some protocols also include oral formulations. Your provider will determine the optimal dosing and route based on your weight management goals.
All dosing is determined by your licensed provider based on your health profile.
Do not self-administer without medical supervision.
AOD-9604
The fat-burning fragment of growth hormone for targeted weight management.
Starting at
$179/month
All plans include doctor review, personalized treatment plan, and 24/7 provider access.
Unlimited 24/7 support
No hidden fees
No insurance required
Same price, every dose
AOD-9604 is administered as a subcutaneous injection, typically once daily in the morning on an empty stomach. Some protocols also include oral formulations. Your provider will determine the optimal dosing and route based on your weight management goals.
All dosing is determined by your licensed provider based on your health profile. Do not self-administer without medical supervision.
- Origin
- HGH fragment 177-191
- Target
- Adipose tissue (fat)
- Form
- Injectable / Oral
- Availability
- Prescription only
No. AOD-9604 is a small fragment of the growth hormone molecule (amino acids 177-191) that only replicates the fat-burning effects of HGH. It does not have growth-promoting, blood sugar, or IGF-1 effects.
No. Clinical studies have confirmed that AOD-9604 does not affect glucose metabolism or insulin sensitivity, making it distinct from full-length growth hormone.
Weight management results with AOD-9604 typically become apparent over 8-12 weeks of consistent use, combined with appropriate diet and exercise. Early changes in body composition may be noticed sooner.
How AOD-9604 works
AOD-9604 is the C-terminal fragment of human growth hormone (hGH 177-191) with an additional tyrosine residue. It mimics the fat-burning action of HGH by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage) in adipose tissue. Crucially, it does this without affecting blood sugar levels, IGF-1 production, or triggering cellular proliferation — making it a targeted metabolic agent without the systemic effects of full-length growth hormone.
Clinical evidence
AOD-9604 has been studied in multiple human clinical trials. A Phase IIb trial involving over 300 obese subjects demonstrated statistically significant weight loss compared to placebo over 12 weeks. The compound received GRAS (Generally Recognized As Safe) designation from the FDA, confirming its favorable safety profile. Studies show it does not affect IGF-1 levels, glucose tolerance, or growth markers — confirming its targeted mechanism of action.
Benefits
No impact on blood sugar
Does not affect glucose metabolism or insulin sensitivity, unlike full-length HGH.
No growth-promoting effects
Isolated fat-burning mechanism without IGF-1 elevation or cellular proliferation.
GRAS-designated safety
Received GRAS (Generally Recognized As Safe) status from the FDA for food applications.
Targeted fat metabolism
Stimulates fat breakdown and inhibits fat storage without systemic growth hormone effects.
No impact on blood sugar
Does not affect glucose metabolism or insulin sensitivity, unlike full-length HGH.
No growth-promoting effects
Isolated fat-burning mechanism without IGF-1 elevation or cellular proliferation.
GRAS-designated safety
Received GRAS (Generally Recognized As Safe) status from the FDA for food applications.
Key takeaways
- Modified fragment of growth hormone targeting only fat metabolism
- Stimulates lipolysis and inhibits lipogenesis
- No effect on blood sugar, IGF-1, or cellular growth
- FDA GRAS-designated safety status
- Clinically studied in large-scale human trials
Bundle savings
Savings apply when multiple peptides are prescribed.
| BUNDLE SIZE | INCLUDED | SAVINGS |
|---|---|---|
| 2 Peptides | Simple paired therapy | SAVE 20• |
| 3 Peptides | Multi-pathway plan | SAVE 30• |
| 4 Peptides | Full personalized set | BEST VALUE |
• Results vary. Prescribed only when clinically appropriate.
Peptide Library
Each plan may include several of the following formulations.
The science behind it
Proven science
Every peptide we offer is backed by peer-reviewed research and clinical data. Our medical team stays current with the latest findings to ensure your protocol reflects the best available science.
Discreet delivery
Your medications arrive in unmarked, temperature-controlled packaging shipped directly from licensed compounding pharmacies. Privacy and quality guaranteed at every step.
Doctor-supervised safety
Every treatment is prescribed and monitored by a licensed physician. Regular check-ins, lab reviews, and dosage adjustments ensure your peptide therapy is safe and effective throughout your journey.
Clinician-Led Care
Eligibility check
Quick online assessment
Consultation
Licensed provider reviews your medical history
Prescription
Medication shipped directly once approved
Follow-ups
Ongoing support and check-ins
Eligibility check
Quick online assessment
Consultation
Licensed provider reviews your medical history
Prescription
Medication shipped directly once approved
Follow-ups
Ongoing support and check-ins
Secure telehealth · GDPR-compliant · Pharmacy-grade compounding.
Check eligibility →
Not for self-administration. Reviewed by a medical provider.
Medication made affordable
Capsules
$179/mo
Single Peptide
$229/mo
Double Combo
$349/mo
Triple Combo
$479/mo
Capsules
$179/mo
Single Peptide
$229/mo
Double Combo
$349/mo
Triple Combo
$479/mo
All plans include a doctor review, personalized treatment plan (if approved), and 24/7 access to a licensed provider in your state.
Related treatments
METABOLIC
GLP-1 Therapy
Clinically studied peptides designed to target metabolism, recovery, energy, and longevity.
Learn more →METABOLIC
MOTS-C
The mitochondrial peptide for metabolic health and cellular energy.
Learn more →METABOLIC
Tesamorelin
FDA-studied GHRH analog for visceral fat reduction and metabolic health.
Learn more →Frequently asked questions
No. AOD-9604 is a small fragment of the growth hormone molecule (amino acids 177-191) that only replicates the fat-burning effects of HGH. It does not have growth-promoting, blood sugar, or IGF-1 effects.
No. Clinical studies have confirmed that AOD-9604 does not affect glucose metabolism or insulin sensitivity, making it distinct from full-length growth hormone.
Weight management results with AOD-9604 typically become apparent over 8-12 weeks of consistent use, combined with appropriate diet and exercise. Early changes in body composition may be noticed sooner.
Yes, AOD-9604 and GLP-1 therapy target weight management through different mechanisms and can be complementary under physician guidance. Your provider will design the optimal combination protocol.
AOD-9604 has received FDA GRAS designation and has demonstrated a favorable safety profile in clinical trials. Long-term use should be supervised by your provider with regular monitoring.
Begin your health journey today
Doctor-guided peptide treatments personalized to your health goals. Start with a free consultation
Starting at
$179/month
All plans include doctor review, personalized treatment plan, and 24/7 provider access.